Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis

Diurnal Variation of Corneal Dendritic Cell Density

(2022) Sultan Alotaibi et al.   CURRENT EYE RESEARCH

A circulating, disease-specific, mechanism-linked biomarker for ATTR polyneuropathy diagnosis and response to therapy prediction

(2021) Xin Jiang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy

(2021) Michael Fleischer et al.   Journal of Neuroinflammation

Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression

(2021) David Adams et al.   Orphanet Journal of Rare Diseases

Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel

(2021) Jeremy Chung Bo Chiang et al.   Scientific Reports

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

(2020) David Adams et al.   JOURNAL OF NEUROLOGY

Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2‐year update from the open‐label extension of the NEURO‐TTR trial

(2020) T. H. Brannagan et al.   EUROPEAN JOURNAL OF NEUROLOGY

Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature

(2020) Maike F. Dohrn et al.   JOURNAL OF NEUROLOGY

Corneal sub‐basal whorl‐like nerve plexus: a landmark for early and follow‐up evaluation in transthyretin familial amyloid polyneuropathy

(2020) Y. Zhang et al.   EUROPEAN JOURNAL OF NEUROLOGY

Early changes of nerve integrity in preclinical carriers of hereditary transthyretin Ala117Ser amyloidosis with polyneuropathy

(2020) Ming‐Chang Chiang et al.   EUROPEAN JOURNAL OF NEUROLOGY

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

(2020) David Adams et al.   LANCET NEUROLOGY

Corneal confocal microscopy: ready for prime time

(2019) Ioannis N Petropoulos et al.   Clinical and Experimental Optometry

Inflammatory profiling of patients with familial amyloid polyneuropathy

(2019) Estefania P. Azevedo et al.   BMC Neurology

Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease

(2019) David Adams et al.   Nature Reviews Neurology

Transthyretin cardiac amyloidosis: an update on diagnosis and treatment

(2019) Hiroyuki Yamamoto et al.   ESC Heart Failure

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy

(2018) Hartmut H. Schmidt et al.   MUSCLE & NERVE

Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy

(2018) Teresa Coelho et al.   NEUROLOGY

Transthyretin familial amyloid polyneuropathy: an update

(2017) Violaine Plante-Bordeneuve   JOURNAL OF NEUROLOGY

Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis

(2016) Laura Obici et al.   CURRENT OPINION IN NEUROLOGY

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy

(2016) David Adams et al.   CURRENT OPINION IN NEUROLOGY

Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe

(2016) Yesim Parman et al.   CURRENT OPINION IN NEUROLOGY

“Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy

(2016) Isabel Conceição et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy

(2016) Haruki Koike et al.   NEUROLOGY

Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?

(2016) D. Adams et al.   REVUE NEUROLOGIQUE

Potential Role of In Vivo Confocal Microscopy for Imaging Corneal Nerves in Transthyretin Familial Amyloid Polyneuropathy

(2016) Antoine Rousseau et al.   JAMA Ophthalmology

Rapid progression of familial amyloidotic polyneuropathy

(2015) David Adams et al.   NEUROLOGY

Early Detection of Nerve Fiber Loss by Corneal Confocal Microscopy and Skin Biopsy in Recently Diagnosed Type 2 Diabetes

(2014) D. Ziegler et al.   DIABETES

Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs

(2014) Adam Castaño et al.   HEART FAILURE REVIEWS

Online Registry for Mutations in Hereditary Amyloidosis Including Nomenclature Recommendations

(2014) Dorota M. Rowczenio et al.   HUMAN MUTATION

Corneal confocal microscopy is efficient, well-tolerated, and reproducible

(2013) Albert Gordon Smith et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Guideline of transthyretin-related hereditary amyloidosis for clinicians

(2013) Yukio Ando et al.   Orphanet Journal of Rare Diseases

Distribution of Antigen Presenting Cells in the Human Cornea: Correlation of In Vivo Confocal Microscopy and Immunohistochemistry in Different Pathologic Entities

(2012) Wolfgang J. Mayer et al.   CURRENT EYE RESEARCH

Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective

(2012) C. Rapezzi et al.   EUROPEAN HEART JOURNAL

Corneal confocal microscopy detects small-fiber neuropathy in Charcot-Marie-Tooth disease type 1A patients

(2012) Mitra Tavakoli et al.   MUSCLE & NERVE

In VivoConfocal Microscopy in Dry Eye Disease and Related Conditions

(2012) Albert Alhatem et al.   Seminars in Ophthalmology

Familial amyloid polyneuropathy

(2011) Violaine Planté-Bordeneuve et al.   LANCET NEUROLOGY

In VivoConfocal Microscopy of Hereditary Sensory and Autonomic Neuropathy

(2009) Tatsuya Mimura et al.   CURRENT EYE RESEARCH